Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues.
Growth hormone secretagogues (GHSs) stimulate growth hormone (GH) secretion, which is lipolytic. Here we compared the effects of twice daily s.c. treatment of GH and the GHS, ipamorelin, on body fat in GH-deficient (lit/lit) and in GH-intact (+/lit and +/+) mice. In +/lit and lit/lit mice ipamorelin induced a small (15%) increase in body weight by 2 weeks, that was not further augmented by 9 weeks. GH treatment markedly enhanced body weight in both groups. Ipamorelin also increased fat pad weights relative to body weight in both lit/lit and +/lit mice. Two weeks GHS treatment (ipamorelin or GHRP-6) also increased relative body fat, quantified by in vivo dual energy X-ray absorpiometry (DEXA) in GH-intact mice. GH decreased relative fat mass in lit/lit mice and had no effect in GH-intact mice. Treatment with GHS, but not GH, increased serum leptin and food intake in GH-intact mice. Thus, GHSs increase body fat by GH-independent mechanisms that may include increased feeding.
Lall
S
S
Department of Physiology, University of Cambridge, Downing Street, Cambridge, CB2 3EG, United Kingdom.
Tung
L Y
LY
Ohlsson
C
C
Jansson
J O
JO
Dickson
S L
SL
D000273:Adipose Tissue / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D005260:Female; D013006:Growth Hormone / Q000172:deficiency / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D006579:Heterozygote; D006728:Hormones / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009842:Oligopeptides / Q000494:pharmacology*; D015430:Weight Gain
D006728:Hormones; D009842:Oligopeptides; D013006:Growth Hormone; C114611:ipamorelin